Validation Study Sample Clauses

Validation Study. The Validation Study together with Target Value Design will define the Base Program, Target Cost, and the Milestone Schedule. It will also: • include each item identified in the Validation Study; • include a detailed breakdown of all projected Chargeable Costs sufficient to allow PMT to confirm that there is a reasonable probability of delivering the Base Program for the Target Cost within the Contract Time.
Sample 1Sample 2
AutoNDA by SimpleDocs
Validation Study. The Parties anticipate that certain of BioTE’s certified healthcare providers will conduct a year-long validation study. The Parties further anticipate that Xxxxxx will provide up to, but not more than, [***] in product and AgeBio Testing toward implementing and conducting the validation study. The Parties agree to provide an appropriate attribution to Xxxxxx’x participation and assistance in the validation study upon publication of the results of such study.
Sample 1
Validation Study 
Sample 1Sample 2

Related to Validation Study

  • Clinical Studies The animal and other preclinical studies and clinical trials conducted by the Company or on behalf of the Company were, and, if still pending are, to the Company’s knowledge, being conducted in all material respects in compliance with all Applicable Laws and in accordance with experimental protocols, procedures and controls generally used by qualified experts in the preclinical study and clinical trials of new drugs and biologics as applied to comparable products to those being developed by the Company; the descriptions of the results of such preclinical studies and clinical trials contained in the Registration Statement and the Prospectus are accurate and complete in all material respects, and, except as set forth in the Registration Statement and the Prospectus, the Company has no knowledge of any other clinical trials or preclinical studies, the results of which reasonably call into question the clinical trial or preclinical study results described or referred to in the Registration Statement and the Prospectus when viewed in the context in which such results are described; and the Company has not received any written notices or correspondence from the FDA, the EMA, or any other domestic or foreign governmental agency requiring the termination, suspension or modification of any preclinical studies or clinical trials conducted by or on behalf of the Company that are described in the Registration Statement and the Prospectus or the results of which are referred to in the Registration Statement and the Prospectus.

Time is Money Join Law Insider Premium to draft better contracts faster.